Showing results (2081-2090 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|November 27, 2007
Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES)Manfred Hauben, Lester Reich, Charles M Gerrits, et al.
Drug Safety|November 26, 2008
Long-term consequences of drugs on the paediatric cardiovascular systemElizabeth Hausner, Monica L Fiszman, Joseph Hanig, et al.
Drug Safety|November 26, 2008
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reportingMarco Tuccori, Francesco Lapi, Arianna Testi, et al.
Drug Safety|November 26, 2008
Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the NetherlandsPetal A H M Wijnen, Marjolein Drent, Patty J Nelemans, et al.
Drug Safety|November 26, 2008
Serious events with infliximab in patients with inflammatory bowel disease: a 9-year cohort study in the NetherlandsHilbert S de Vries, Martijn G H van Oijen, Dirk J de Jong
Drug Safety|July 3, 2007
Risk of diabetic ketoacidosis after exposure to risperidone or olanzapineKrishnan Ramaswamy, Chris M Kozma, Henry Nasrallah
Drug Safety|July 3, 2007
Signal detection: historical backgroundToine C G Egberts
Drug Safety|July 3, 2007
Prescription-event monitoring: developments in signal detectionGermano Ferreira
Drug Safety|April 3, 2009
Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactiveJohn Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bruyn, et al.
Drug Safety|October 26, 2022
A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 DiabetesDavid Tak Wai Lui, Tingting Wu, Ivan Chi Ho Au, et al.
Pageof 309